MUELLER PETER 4
4 · BioXcel Therapeutics, Inc. · Filed May 28, 2019
Insider Transaction Report
Form 4
MUELLER PETER
Director
Transactions
- Award
Stock Option (Right to Buy)
2019-05-23+14,700→ 14,700 totalExercise: $10.04Exp: 2029-05-23→ Common Stock (14,700 underlying)
Footnotes (1)
- [F1]The option will vest in full and become exercisable on the first anniversary of the grant date.